Similac NeoSure Infant Formula with Iron, For Babies Born Prematurely, Ready-to-Feed bottles, 1 qt (Pack of 6)
Original price was: $58.14.$53.60Current price is: $53.60.
Price: $58.14 - $53.60
(as of Jun 22,2022 17:48:16 UTC – Details)
Similac NeoSure Infant Formula is a nutrient-enriched baby formula that promotes excellent catch-up growth during your premature baby’s first 12 months including better gains in weight, length and head circumference when compared to premature babies fed term infant formulas*. Help support her development in the first full year with specialized nutrition from the #1 brand of premature formula** Also available in powder. *Compared to infants fed a formula without DHA and ARA in a clinical trial with Similac Special Care and Similac Expert Care NeoSure Infant formulas with iron **Total US Premature infant formula all outlets as of 12/31/16, Nielsen data)
Product Dimensions : 10.63 x 8.19 x 8.69 inches; 10.9 Pounds
Manufacturer recommended age : 0 – 10 months
Item model number : 070074674421
Date First Available : March 25, 2009
Manufacturer : Alere
ASIN : B00KQ0GNC8
Country of Origin : USA
An easy-to-digest milk-based formula that contains increased protein, energy, vitamins and minerals compared to standard infant formula as well as extra calories for growth in baby’s first year
The only nutrient-enriched formula for preterm infants with data to show it promoted greater rates of growth than a term infant formula during the first year of life for babies born prematurely.Kosher
Includes DHA and ARA, special nutrients found in breast milk that are important for helping support brain and eye development and calcium and phosphorus for baby’s growing bones
From the #1 brand of premature formula (*Total US Premature infant formula all outlets as of 12/31/16, Nielsen data)
User Reviews
Be the first to review “Similac NeoSure Infant Formula with Iron, For Babies Born Prematurely, Ready-to-Feed bottles, 1 qt (Pack of 6)”
Original price was: $58.14.$53.60Current price is: $53.60.
There are no reviews yet.